Phathom Pharmaceutic...
NasdaqGS:PHAT
$ 12,63
$-0,01 (-0,08%)
12,63 $
$-0,01 (-0,08%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-2,06
Earnings Per Share
$2,22
Revenue Per Share
87,09%
Gross Margin %
$1,00 B
Market Cap
$0,56 B
Long-Term Debt
Earnings Per Share
$-2,06
Revenue Per Share
$2,22
Gross Margin %
87,09%
Market Cap
$1,00 B
Long-Term Debt
$0,56 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020
EPS Earnings Per Share $-2,06 $-5,29 $-2,53 $-5,05 $-3,89 $-3,88
Earnings Earnings $-162,33M $-368,40M $-147,95M $-210,69M $-118,92M $-110,85M
RPS Revenue Per Share $0,00 $2,22 $0,79 $0,01 $0,00 $0,00 $0,00
Revenue Revenue $0,00M $175,11M $55,25M $0,68M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $-199,97M $-266,77M $-137,58M $-146,53M $-148,62M $-69,69M
FCF Free Cash Flow $0,00M $-199,95M $-266,91M $-157,00M $-147,57M $-162,36M $-70,73M
OM Operating Margin 0,00% -91,36% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 87,09% 85,57% 75,51% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $-2,29 $-4,22 $-2,71 $-3,77 $-4,03 $-2,13
LT Debt Long-Term Debt N/A $559,21M $534,67M $437,66M $204,79M $89,67M $39,63M
Sha. Stocks 78,8M 78,8M 69,64M 58,48M 41,72M 30,57M 28,57M
×